ENSO
Wearable device shown in clinical trials to solve pain 2x better than Vicodin
Top Tier Investor
Overview
1.5 billion people worldwide live with chronic pain, and the best option they have are drugs like Vicodin that have terrible side effects and make people feel sick.
Enso has developed the first opioid-free, wearable device clinically proven to solve pain better than Vicodin. It works by delivering a patented electrical stimulation treatment that relaxes the muscles and calms the nerves wherever it is applied, and it's all controlled via an app on your smartphone.
Enso is being used to solve chronic and acute pain at over 100 medical centers in the US such as Stanford, Harvard and Cedars-Sinai. The device is covered by the VA Hospitals and workers compensation insurance plans and is expected to be covered by other major insurance plans by 2020.
Enso has developed the first opioid-free, wearable device clinically proven to solve pain better than Vicodin. It works by delivering a patented electrical stimulation treatment that relaxes the muscles and calms the nerves wherever it is applied, and it's all controlled via an app on your smartphone.
Enso is being used to solve chronic and acute pain at over 100 medical centers in the US such as Stanford, Harvard and Cedars-Sinai. The device is covered by the VA Hospitals and workers compensation insurance plans and is expected to be covered by other major insurance plans by 2020.
Industries
Biotechnology
Life Sciences
Consumer Electronics
Digital Health